Atrial fibrillation is associated with severe acute ischemic stroke.
about
Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia?Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devicesClinical and Economic Implications of AF Related StrokeSex Differences in Outcomes among Stroke Survivors with Non-Valvular Atrial Fibrillation in China.An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.Atrial fibrillation in patients with ischemic stroke: A population-based study.Mexican Americans with atrial fibrillation have more recurrent strokes than do non-Hispanic whites.Stroke and bleeding risk in atrial fibrillation.Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis.Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillation.Comparison of costs and discharge outcomes for patients hospitalized for ischemic or hemorrhagic stroke with or without atrial fibrillation in the United States.Neurologic symptom severity after a recent noncardioembolic stroke and recurrent vascular riskNew oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disordersAntithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.Stroke Prevention in Atrial Fibrillation: Where are We Now?Costs and clinical consequences of suboptimal atrial fibrillation management.A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: balancing the risks and benefits.Health technology assessment and its role in the future development of the Indian healthcare sector.Emerging role of direct thrombin inhibitors in nonvalvular atrial fibrillation: potential and peril.The Association between Job Strain and Atrial Fibrillation: Results from the Swedish WOLF Study.Contemporary approaches to managing atrial fibrillation: A survey of Australian general practitioners.Stroke prevention in atrial fibrillation: concepts and controversiesA multidisciplinary atrial fibrillation clinic.Predicting Mortality in Patients With "Malignant" Middle Cerebral Artery Infarction Using Susceptibility-Weighted Magnetic Resonance Imaging: Preliminary Findings.Admission clinical characteristics and early clinical outcomes among acute ischemic stroke patients.Outcome Predictors in First-Ever Ischemic Stroke Patients: A Population-Based StudyAtrial fibrillation is a predictor of in-hospital mortality in ischemic stroke patientsEfficacy And Safety of Dabigatran Etexilate Utilization With Concomitant Dual Antiplatelet Therapy In Atrial FibrillationDabigatran, A Direct Thrombin Inhibitor, In Atrial Fibrillation: Is It Already Time For A Change In Oral Anticoagulation Therapy?Underutilization of Warfarin Therapy in Elderly Patients with Atrial Fibrillation - Fear or False Sense of Security!European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial FibrillationAssociation of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation.A new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarinAssociation of serum bilirubin with ischemic stroke outcomes.Antiarrhythmic Effect Of Antioxidants In Patients With Atrial Fibrillation.Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.Solutions to Reduce Cardiovascular Events in Patients with Atrial Fibrillation.Managing atrial fibrillation in the global community: The European perspective.
P2860
Q26800991-35537687-E37C-4683-8ADF-D88B334A0EAFQ28074643-6E25D65B-AD05-4F8E-B18E-529235C1AE59Q28077788-BB75BDED-C38D-4DA0-A5AC-9E1167957CFAQ33606961-1B791764-A227-4905-87FB-387800DC754EQ33811339-31E96E05-7AD9-42C3-9901-B8298B29A6E3Q33876319-E5812DAD-7AED-40B2-BA14-00A0547BDB55Q34144002-2566C671-8B7F-4290-80D1-796C32A8442DQ34164148-2DA1BF03-0087-40E9-90FF-28929EA35898Q34269633-685B936E-7AD4-40DB-A82E-3F09B1ED7A9EQ34343826-DC23FA0E-D6E1-4B8C-9F79-BA25BF996073Q34502114-E04FC6ED-9221-4A6A-912F-9F861C485580Q35118898-74F94433-0AD1-40FE-9051-F08B7E99E4B4Q35232308-8FE7E77B-FD20-4818-88A9-3F39C8E69331Q35533505-CE7A5035-2AB8-4E04-87CF-D24794149B17Q35739671-79C8BF51-1401-45F2-B624-789C8B1D17E1Q35777336-30BA7ABD-2D8B-49E0-A6C0-49891702ECD2Q35811581-0BCFD2A1-688D-4803-917C-760C7EC84C4FQ35885128-E3CEF4FD-3315-4AE0-8177-9CAC67B472C7Q35986742-0E16F5D3-C7FB-4C39-89CF-7FAE27CD9A5BQ36021214-13DA9A5B-AAA5-4591-86C6-506CB5A2205EQ36094367-2A2D95E0-0F28-44E9-98CC-C04710EEEA73Q36236525-A6FFAA3E-7FB4-4E0A-8CBE-4FF790D1E7F9Q36360590-90674EB4-B776-437C-B1D3-2DBE01B193AFQ36382375-75627C3A-3131-423E-9CE8-264BB6FD53B5Q36644851-1265E0C9-EA1F-4D11-A5AC-31DC52D2529FQ36653568-6BFEAF30-9E13-4D2F-AA26-7A97673D200CQ36680044-C92AF2B0-CB41-4A7A-BDC4-D400F635D858Q36979296-5632347F-A623-43C5-8E7F-62B69A4CE721Q37070706-3984FA44-034E-47F5-BABB-363CC908CBA1Q37115151-62831072-2949-4A73-8C32-DBF46D643BA3Q37115353-BA6D2E02-4C00-48FF-883D-1BE1903C893BQ37115740-675C58C2-3BEE-4218-A4F0-4B7270EE4C81Q37157549-2351F067-8E7C-422C-B4AE-82F1DB10C10AQ37281768-EBC4C28D-1295-4386-8664-77213C83DE6DQ37312021-2FE4DA9B-70EB-48D5-98B5-7FCBF7A9E8DFQ37317798-E5CB06F6-081E-4769-84E6-B4D9C21AE370Q37384597-DEDF01B3-9D86-44BA-820A-55D1AEE8DF10Q37495877-0692AB19-F1BD-4C59-87B3-FC48391280CBQ37496280-812F10C3-2C3E-4210-88FA-CC1813990235Q37659215-E1B26B27-C5C6-4383-80C1-7D5B2247EEC1
P2860
Atrial fibrillation is associated with severe acute ischemic stroke.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Atrial fibrillation is associated with severe acute ischemic stroke.
@ast
Atrial fibrillation is associated with severe acute ischemic stroke.
@en
Atrial fibrillation is associated with severe acute ischemic stroke.
@nl
type
label
Atrial fibrillation is associated with severe acute ischemic stroke.
@ast
Atrial fibrillation is associated with severe acute ischemic stroke.
@en
Atrial fibrillation is associated with severe acute ischemic stroke.
@nl
prefLabel
Atrial fibrillation is associated with severe acute ischemic stroke.
@ast
Atrial fibrillation is associated with severe acute ischemic stroke.
@en
Atrial fibrillation is associated with severe acute ischemic stroke.
@nl
P2093
P356
P1433
P1476
Atrial fibrillation is associated with severe acute ischemic stroke.
@en
P2093
Douglas A Dulli
Heather Stanko
Ross L Levine
P304
P356
10.1159/000068743
P577
2003-03-01T00:00:00Z